MedPath

Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation.

Phase 4
Completed
Conditions
Atrial Fibrillation
Interventions
Registration Number
NCT00232245
Lead Sponsor
Melbourne Health
Brief Summary

The purpose of this study is to investigate whether fish oil supplements may reduce the frequency and duration of paroxysmal atrial fibrillation episodes.

Atrial fibrillation is a heart condition which effects a large percentage of the population .

Atrial fibrillation is a condition frequently experienced by people who have had pacemakers inserted .

Certain Pacemakers have sophisticated monitoring features that are able to recognise episodes of atrial fibrillation.

Fish oil supplements may be of benefit to patients with heart problems.Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances.

By interrogating pacemakers this study will investigate the effect of fish oil supplements on the frequency and duration of episodes of atrial fibrillation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Patients who have had at least 2 previous episodes of atrial fibrillation and an implanted pacemaker.
Exclusion Criteria
  • Patients with chronic atrial fibrillation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fish oilFish oilPatients prescribed 6g/day of fish oil containing total 1.8 g of EPA+DHA in a 1.5:1 ratio
Primary Outcome Measures
NameTimeMethod
Atrial tachycardia and atrial fibrillation burden18 months
Secondary Outcome Measures
NameTimeMethod
Frequency and duration of atrial tachycardia/fibrillation episodes18 months

Trial Locations

Locations (1)

Royal Melbourne hospital

🇦🇺

Melbourne, Victoria, Australia

© Copyright 2025. All Rights Reserved by MedPath